HPLC Analysis of Recombinant Tumor Necrosis Factor Receptor-Fc Fusion Protein (rhTNFR-Fc) on Zenix® SEC-300 versus SRT® SEC-300, Effect of Particle Size on Resolution
![HPLC Analysis of Recombinant Tumor Necrosis Factor Receptor-Fc Fusion Protein (rhTNFR-Fc) on Zenix® SEC-300 versus SRT® SEC-300, Effect of Particle Size on Resolution application for HPLC](/deepweb/assets/sigmaaldrich/product/images/141/664/12ed5b68-e1f9-4776-962a-b7f0328881d4/800/12ed5b68-e1f9-4776-962a-b7f0328881d4.jpg)
CONDITIONS
column
Zenix SEC-300, 30 cm x 7.8 mm I.D., 3 μm, 300 Å particles (Z777051)
column
SRT SEC-300, 30 cm x 7.8 mm I.D., 5 μm, 300 Å particles (Z777051) (Z777033)
mobile phase
150 mM sodium phosphate, pH 7.0
flow rate
1 mL/min
detector
UV, 214 nm
injection
20 μL
sample
Recombinant tumor necrosis factor receptor-Fc fusion protein (rhTNFR-Fc), including oligomers (440 kD and 360 kD), monomer (150 kD), and impurity (120 kD)
Description
Legal Information
SRT is a registered trademark of Sepax Technologies
Zenix is a registered trademark of Sepax Technologies